IP Library Granted Patent US 12,226,219
Granted Patent B1
US 12,226,219 · App. 17/193,924 · Granted Feb 18, 2025

Detecting nonsustained ventricular tachycardia in a wearable cardioverter defibrillator

Inventors: Jaeho Kim (Redmond, WA); Joseph Sullivan (Kirkland, WA)
Assignee: West Affum Holdings DAC
A61B5/366A61B5/02455A61B5/352A61B5/363A61B5/7246A61N1/3904A61N1/3943A61N1/395A61N1/3987
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,219
App. No.
17/193,924
Granted
Feb 18, 2025
Kind
B1
Abstract

In one embodiment, a method to monitor a patient's heart health is described. The method may include processing at least one electrocardiogram (ECG) signal and diagnosing an episode of nonsustained ventricular tachycardia (NSVT) based at least in part on the processing of the at least one ECG signal. In some embodiments, the NSVT episode may satisfy an NSVT time duration and a QRS criterion. The NSVT time duration may be between 5 seconds and 15 seconds. In some instances, the QRS criterion may be a temporary QRS template of two sequential incoming QRS complexes. In some embodiments, the method may determine a similarity between the temporary QRS template and at least two subsequent QRS complexes by calculating a feature correlation coefficient between the QRS template and the subsequent QRS complexes.

Claims (24)

1. A method of providing targeted therapy to a heart of a patient based on determination of a category of cardiac episodes, the method comprising:

receiving, by a processor, a first electrocardiogram (ECG) signal from one or more external electrodes;

receiving, by the processor, a second ECG signal from the one or more external electrodes;

detecting, by the processor, a first QRS complex in the first ECG signal;

detecting, by the processor, a second QRS complex in the second ECG signal;

calculating, by the processor, a Feature Correlation Coefficient (FCC) based, at least in part, on the first QRS complex and the second QRS complex;

determining, by the processor, that the first ECG signal and the second ECG signal are indicative of an episode of sustained ventricular tachycardia (SVT) based, at least in part, on the calculated FCC;

and

providing therapy to the heart of the patient based, at least in part, on a determination that the episode of SVT is indicated.

2. The method of claim 1 , wherein the episode of SVT is detected, at least in part, when a QRS criterion is satisfied.

3. The method of claim 2 , wherein the QRS criterion comprises satisfying a FCC threshold between a temporary QRS template formed using at least two sequential QRS complexes and a subsequent QRS complex.

4. The method of claim 3 , wherein calculating the FCC comprises calculating a similarity between at least one of the first QRS complex or the second QRS complex and the temporary QRS template.

5. The method of claim 1 , wherein the episode of SVT is detected, at least in part, when a series of detected QRS complexes comprising the first QRS complex and/or the second QRS complex has a similar normal sinus rhythm (NSR) morphology.

6. The method of claim 1 , further comprising:

storing the episode of SVT based, at least in part, on the determining.

7. A method of categorizing cardiac episodes for treatment of a heart of a patient, the method comprising:

processing at least one electrocardiogram (ECG) signal received from an external electrode;

generating a temporary QRS template of two sequential incoming QRS complexes from the ECG signal;

determining a similarity between the temporary QRS template and at least two subsequent QRS complexes by calculating a feature correlation coefficient (FCC) between the temporary QRS template and the subsequent QRS complexes;

categorizing an episode as potential non-sustained ventricular tachycardia (NSVT) or a sustained ventricular tachycardia (SVT) based, at least in part, on the similarity between the temporary QRS template and the at least two subsequent QRS complexes;

storing the categorized episode of potential NSVT; and

accessing the categorized episode of potential NSVT to determine a risk for the patient to develop SVT, the determination of the risk of SVT resulting in providing therapy for the treatment of the heart of the patient.

8. The method of claim 7 , wherein the episode of potential NSVT is categorized based, at least in part, on when an NSVT time duration and a QRS criterion are satisfied.

9. The method of claim 8 , wherein the NSVT time duration is between 5 seconds and 15 seconds.

Assignments (4)
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DAC
Reel/Frame 060389/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: SULLIVAN, JOSEPH L.; KIM, JAEHO
To: STRYKER CORP
Reel/Frame 058206/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: PHYSIO-CONTROL, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 058206/0823 →
Continuity (1)
Provisional Application 63068781 · Aug 21, 2020
References Cited (104)
US 3724455A · Unger · 1973 [cited by applicant]
US 4583524A · Hutchins · 1986 [cited by applicant]
US 4619265A · Morgan et al. · 1986 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4955381A · Way et al. · 1990 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5228449A · Christ et al. · 1993 [cited by applicant]
US 5348008A · Bornn et al. · 1994 [cited by applicant]
US 5353793A · Born · 1994 [cited by applicant]
US RE34800E · Hutchins · 1994 [cited by applicant]
US 5394892A · Kenny · 1995 [cited by applicant]
US 5405362A · Kramer et al. · 1995 [cited by applicant]
US 5474574A · Payne et al. · 1995 [cited by applicant]
US 5662690A · Cole et al. · 1997 [cited by applicant]
US 5782878A · Morgan et al. · 1998 [cited by applicant]
US 5792204A · Snell · 1998 [cited by applicant]
US 5902249A · Yster · 1999 [cited by applicant]
US 5913685A · Hutchins · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6047203A · Sackner et al. · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6108197A · Janik · 2000 [cited by applicant]
US 6148233A · Owen et al. · 2000 [cited by applicant]
US 6201992B1 · Freeman · 2001 [cited by applicant]
US 6263238B1 · Brewer et al. · 2001 [cited by applicant]
US 6287328B1 · Snyder et al. · 2001 [cited by applicant]
US 6304780B1 · Owen et al. · 2001 [cited by applicant]
US 6319011B1 · Motti et al. · 2001 [cited by applicant]
US 6334070B1 · Nova et al. · 2001 [cited by applicant]
US 6356785B1 · Snyder · 2002 [cited by applicant]
US 6427083B1 · Owen et al. · 2002 [cited by applicant]
US 6437083B1 · Owen et al. · 2002 [cited by applicant]
US 6529875B1 · Nakajima · 2003 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6671545B2 · Fincke · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6762917B1 · Verbiest et al. · 2004 [cited by applicant]
US 7065401B2 · Worden · 2006 [cited by applicant]
US 7559902B2 · Ting et al. · 2009 [cited by applicant]
US 7865238B2 · Brink · 2011 [cited by applicant]
US 7870761B2 · Valentine et al. · 2011 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 8135462B2 · Owen et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8548557B2 · Garstka et al. · 2013 [cited by applicant]
US 8615295B2 · Savage et al. · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8965500B2 · Macho et al. · 2015 [cited by applicant]
US 9008801B2 · Kaib et al. · 2015 [cited by applicant]
US 9089685B2 · Sullivan et al. · 2015 [cited by applicant]
US 9131901B2 · Volpe et al. · 2015 [cited by applicant]
US 9132267B2 · Kaib · 2015 [cited by applicant]
US 9408548B2 · Volpe et al. · 2016 [cited by applicant]
US 9454219B2 · Volpe et al. · 2016 [cited by applicant]
US 9592403B2 · Sullivan · 2017 [cited by applicant]
US 20030158593A1 · Heilman et al. · 2003 [cited by applicant]
US 20050107833A1 · Freeman et al. · 2005 [cited by applicant]
US 20050107834A1 · Freeman et al. · 2005 [cited by applicant]
US 20080312709A1 · Volpe et al. · 2008 [cited by applicant]
US 20090005827A1 · Weintraub et al. · 2009 [cited by applicant]
US 20100007413A1 · Herleikson · 2010 [cited by applicant]
US 20100298899A1 · Donnelly et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120144551A1 · Guldalian · 2012 [cited by applicant]
US 20120150008A1 · Kaib et al. · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120265265A1 · Razavi et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130245388A1 · Rafferty et al. · 2013 [cited by applicant]
US 20130274565A1 · Langer et al. · 2013 [cited by applicant]
US 20130317852A1 · Worrell et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20140005988A1 · Brockway · 2014 [cited by examiner]
US 20140025131A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140070957A1 · Longinotti-Buitoni et al. · 2014 [cited by applicant]
US 20140163663A1 · Poddar et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20140378812A1 · Saroka et al. · 2014 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150328472A1 · Sullivan et al. · 2015 [cited by applicant]
US 20160004831A1 · Carlson et al. · 2016 [cited by applicant]
US 20160082277A1 · Foshee, Jr. et al. · 2016 [cited by applicant]
US 20160135706A1 · Sullivan · 2016 [cited by examiner]
US 20180348759A1 · Freeman · 2018 [cited by examiner]
US 20210393966A1 · Gunderson · 2021 [cited by examiner]
WO 1998039061A2 · 1998 [cited by applicant]
Klein, H. U., Goldenberg I., & Moss, A. J., Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update, European Heart Journal, May 31, 2… [cited by applicant]
LIFECOR LifeVest System Model WCD 3100 Operator's Manual, 2006, PN 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. [cited by applicant]
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. [cited by applicant]
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. [cited by applicant]
The LifeVest Network/Patient Data Management System, Zoll, 2015, 20C0503 Rev A. [cited by applicant]
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, p. 2065-2071. [cited by applicant]
The LifeVest Network/Patient Data Management System, Zoll, 2015, 2000503 Rev A. [cited by applicant]